证券日报网讯 新和成（002001）9月30日在互动平台回答投资者提问时表示，公司生产的维生素A和维 生素E产品涵盖了饲料级、食品级和医药级等多个级别，以满足不同领域的需求。在高端维生素A和维 生素E方面，公司拥有相关产品，并且在全球范围内具有显著的竞争力。公司已获得美国、欧洲、日本 等主要市场的市场准入资格，产品在这些市场得到了广泛认可。 ...

公 司 研 究 / 基 础 化 工 / 证 券 研 究 报 告 新和成（002001）财报点评 Q2 维生素价格环比下降，蛋氨酸项目 投入试运行 2025 年 09 月 30 日 【投资要点】 挖掘价值 投资成长 增持（维持） 东方财富证券研究所 证券分析师：张志扬 证书编号：S1160524100006 证券分析师：梅宇鑫 证书编号：S1160525020002 相对指数表现 -20% -12% -4% 4% 12% 20% 2024/9 2025/3 2025/9 新和成 沪深300 | 基本数据 | | | --- | --- | | 总市值（百万元） | 72,993.76 | | 流通市值（百万元） | 72,125.47 | | 52 周最高/最低（元） | 25.19/19.55 | | 52 周最高/最低（PE） | 13.19/10.24 | | 52 周最高/最低（PB） | 2.64/2.05 | | 52 周涨幅（%） | 21.48 | | 52 周换手率（%） | 51.74 | 注：数据更新日期截止 2025 年 09 月 29 日 相关研究 《公司产品量价齐升，2024 年保持 ...

Financial Performance - In the first half of 2025, the company achieved a revenue of 11.101 billion yuan, a year-on-year increase of 12.76% [1] - The net profit attributable to shareholders was 3.603 billion yuan, reflecting a significant year-on-year growth of 63.46% [1] - For Q2 2025, the company reported a revenue of 5.661 billion yuan, up 5.89% year-on-year and 4.07% quarter-on-quarter [1] - The net profit for Q2 2025 was 1.723 billion yuan, showing a year-on-year increase of 29.12% but a quarter-on-quarter decrease of 8.32% [1] Product Development and Market Expansion - The company is actively promoting new products such as HA series and tryptophan while maintaining its market advantage in existing products [2] - The liquid methionine project in partnership with Sinopec is in trial production, and the Tianjin nylon new materials project has completed compliance approvals [2] - Other technical upgrades and management improvement projects are progressing steadily, with new project planning being conducted in an orderly manner [2] Pricing and Market Trends - Prices for major products showed a mixed trend, with some prices decreasing quarter-on-quarter while others increased year-on-year [3] - The average prices for vitamins A, E, D3, C, and methionine in Q2 2025 were 73.67, 104.38, 237.15, 21.04, and 22.27 yuan/kg, respectively [3] - The nutrition products segment generated a revenue of 7.200 billion yuan in H1 2025, a year-on-year increase of 7.78%, with a gross margin of 47.79%, up 11.93 percentage points year-on-year [3] Future Outlook - The company is a leading player in the domestic market for vitamins A, E, and methionine, with the methionine project expected to gradually contribute to profits [4] - Revenue forecasts for 2025-2027 are projected at 23.938 billion, 26.136 billion, and 28.785 billion yuan, with net profits of 6.741 billion, 7.139 billion, and 7.641 billion yuan, respectively [4] - The price-to-earnings ratios for 2025-2027 are estimated to be 10.83, 10.23, and 9.55 times, maintaining a "buy" rating [4]

Investment Rating - The industry investment rating is "Outperform" and is maintained [2] Core Views - The report highlights that the basic chemical sector has shown a decline of 1.33% this week, underperforming the CSI 300 index by 0.89 percentage points [6][19] - Key companies to focus on include Wanhua Chemical, Yangnong Chemical, Hengli Petrochemical, and Hualu Hengsheng, with a specific interest in agricultural chemicals and technology sectors such as liquid cooling and PCB supply chains [5] Summary by Sections Industry Overview - The closing index for the basic chemical sector is at 4048.88, with a weekly high of 4123.45 and a low of 2721.92 [2] Price Movements - Major price increases were observed in products such as liquid chlorine (up 22.93%), dichloromethane (up 19.44%), and bismuth ingots (up 12.39%) [9][25] - Conversely, prices for vitamin E decreased by 10.00%, and other products like β-methyl naphthalene and trichloro-sucrose also saw significant declines [10][27] Stock Performance - Notable stock performances included significant gains for companies like Kaimete Gas (up 28.62%) and Guangdong Hongda (up 22.93%), while companies like Runyang Technology and Wankai New Materials experienced declines of 11.48% and 10.42%, respectively [7][22] Key Company Ratings - Wanhua Chemical is rated "Buy" with a closing price of 65.3 and a market cap of 204.45 billion [12] - Yangnong Chemical is also rated "Buy" with a closing price of 71.2 and a market cap of 28.86 billion [12] - Other companies such as Meihua Biological and Bailong Chuangyuan remain unrated [12]

Summary of the Conference Call Company and Industry Overview - The conference call focuses on the vitamin industry, particularly the role of vitamins in animal nutrition and the performance of the company Xinhecheng in this sector [2][12][18]. Key Points and Arguments Vitamin Demand in Animal Nutrition - Industrialized farming relies heavily on vitamin additives, with feed demand accounting for approximately 60%, and certain vitamins like A and D3 reaching up to 80% [2][5]. - In 2022, pig and poultry feed constituted 86% of China's total feed demand, with pig feed around 45% and poultry feed at 41% [9]. - The profitability of farming significantly influences vitamin demand, with farmers reducing vitamin usage during low-profit periods [9][10]. Market Dynamics and Trends - The vitamin industry has evolved from monopolies by companies like Merck and Roche to increased competition from Japanese firms and Chinese companies like Xinhecheng and Zhejiang Medicine [2][12]. - The global vitamin market currently faces an oversupply, leading companies to halt production to maintain prices [2][13]. - Seasonal demand for animal nutrition supplements peaks in the fourth quarter due to pre-holiday fattening, while summer demand is relatively low [2][14]. Price Fluctuations and Influencing Factors - Vitamin prices are influenced by environmental policies, raw material supply constraints, and unforeseen events [14][15]. - Historical trends show that demand typically sets the price baseline, while supply determines the price ceiling [15]. Xinhecheng's Strategic Positioning - Xinhecheng is diversifying its portfolio beyond vitamins, focusing on amino acids, flavoring agents, and new materials, which have shown strong growth [4][18]. - The company has established a competitive edge in the flavoring market, achieving a gross margin exceeding 50% [19]. - Xinhecheng's new materials business has also seen rapid growth, with products like PPS and PPA reaching global leading levels [20]. Financial Performance and Future Outlook - In 2024, vitamin E prices were at historical highs, significantly contributing to the company's profits, but overall profit impact from vitamin price fluctuations is limited [21]. - The company is expected to continue providing good shareholder returns, including special dividends in profitable years [24]. Market Conditions for Methionine - The market for methionine is stable, with concerns about price impacts from new production capacity being mitigated by steady demand [22][23]. Additional Important Insights - The vitamin market's supply-demand relationship has historically influenced pricing, with significant fluctuations observed during periods of high profitability in the livestock sector [15][16]. - Xinhecheng's long-term growth potential and strong financial metrics make it an attractive option for long-term investors [24].

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - Recent price increases observed in bio-jet fuel, polysilicon, refrigerants, and EVA, while prices for Vitamin E and other materials have declined [5][9][46] - The demand for lightweight materials is expected to rise due to advancements in robotics and the low-altitude economy, suggesting potential investment opportunities in related companies [5][24][30] Summary by Sections 1. Subsector Tracking - Bio-jet fuel (SAF) price reached 2670 USD/ton, up 1.14% week-on-week, and up 44.01% year-to-date [9] - Polysilicon spot price at 53945 CNY/ton, up 2.65% week-on-week [9] - Refrigerant R32 price at 61500 CNY/ton, up 0.82% week-on-week [9] - EVA market average price at 11150 CNY/ton, up 2.76% week-on-week [9] - Vitamin E price at 55 CNY/kg, down 8.33% week-on-week [4] 2. Key Product Price Trends - The report highlights significant price fluctuations in key chemical materials, with some products experiencing substantial increases while others, like Vitamin E and PA66, have seen declines [4][10] 3. Industry Performance - The basic chemical index increased by 2.40% during the week, ranking 10th among 30 sectors [60] - The overall chemical industry performance has shown noticeable differentiation, with some sectors performing better than others [63] 4. Focus on Lightweight Materials - The report emphasizes the growing importance of lightweight materials in the context of robotics and low-altitude economic activities, indicating a potential increase in demand for materials like PEEK and carbon fiber [5][24][30] 5. Renewable and Modified Plastics - The report discusses the increasing application of renewable plastics and the growing market for special engineering plastics, driven by environmental concerns and technological advancements [48][55]

Market Performance - The new materials sector experienced a decline this week, with the new materials index falling by 0.31%, underperforming the ChiNext index by 2.67% [1][2] - Over the past five trading days, the synthetic biology index decreased by 0.51%, semiconductor materials dropped by 4.74%, and specialty chemicals fell by 1.54%. In contrast, biodegradable plastics saw a slight increase of 0.02%, while industrial gases declined by 1.20%. Battery chemical products surged by 13.36% [1][2] Price Tracking - Amino acids prices showed the following changes: valine at 12,750 CNY/ton (-1.92%), arginine at 22,900 CNY/ton (-1.08%), tryptophan at 39,500 CNY/ton (-4.82%), and methionine at 22,050 CNY/ton (-0.68%) [3] - Prices for biodegradable materials remained stable: PLA (FY201 injection grade) at 17,800 CNY/ton, PLA (REVODE201 blow film grade) at 17,200 CNY/ton, PBS at 17,800 CNY/ton, and PBAT at 9,850 CNY/ton [3] - Vitamin prices were as follows: Vitamin A at 64,000 CNY/ton (unchanged), Vitamin E at 64,500 CNY/ton (-1.53%), Vitamin D3 at 227,500 CNY/ton (unchanged), calcium pantothenate at 40,500 CNY/ton (unchanged), and inositol at 26,000 CNY/ton (unchanged) [3] - Industrial gases and wet electronic chemicals prices remained unchanged: UPSSS grade hydrofluoric acid at 11,000 CNY/ton and EL grade hydrofluoric acid at 5,600 CNY/ton [3] - In the plastics and fibers category, carbon fiber remained at 83,750 CNY/ton (unchanged), polyester industrial yarn at 8,500 CNY/ton (-2.30%), and aramid at 102,700 CNY/ton (+17.62%). The export average price for polyester tire cord fabric in July was 16,353 CNY/ton (-0.61%) [3] Investment Opportunities - The DAC project has been included in Shanghai's 2025 key technology research and development plan, highlighting opportunities in domestic DAC adsorbents and equipment [4] - The recognition and strong support from various government levels for DAC technology mark a significant milestone in addressing climate change and promoting green energy development [5] - The establishment of a thousand-ton demonstration project will provide valuable engineering data and operational experience for future commercial projects, potentially enhancing DAC product performance and reducing capture costs [5] - Companies to watch for key adsorbent materials and related equipment include Blue Sky Technology, Jianlong Micro-Nano, Xizhuang Co., China Energy Construction, GCL-Poly, and United Water [5]

Investment Rating - The report maintains a positive outlook on the basic chemical industry, suggesting that leading companies with significant scale and cost advantages will benefit from economic recovery and demand resurgence [4][8]. Core Insights - The report highlights the recovery of the TDI production facility by Mitsui and the successful commissioning of a new ethylene plant by Jilin Petrochemical, indicating positive developments in the industry [3][4]. - It emphasizes the strong competitive position of domestic tire manufacturers and suggests that rare growth stocks in this sector are worth attention [4]. - The report notes a potential recovery in consumer electronics, recommending upstream material companies as beneficiaries of this trend [4]. - It identifies several resilient cyclical industries, such as phosphate and fluorine chemicals, which are expected to see improved market conditions due to supply constraints and rising demand [5][8]. Summary by Sections Market Performance - The Shanghai Composite Index fell by 1.18%, while the ChiNext Index rose by 2.35%. The CITIC Basic Chemical Index increased by 0.15%, and the Shenwan Chemical Index decreased by 1.36% [14][17]. - The top-performing sub-industries included organic silicon (3.59%), modified plastics (2.46%), and tires (2.22%), while the worst performers were other plastic products (-4.72%) and compound fertilizers (-3.04%) [17][18]. Industry Dynamics - Mitsui's TDI plant is set to resume production after a chlorine leak incident, with expectations of stable product supply [3]. - Jilin Petrochemical's new ethylene plant has successfully started operations, increasing its total ethylene capacity to 1.9 million tons per year [3]. Investment Themes - **Tire Sector**: Domestic tire companies are noted for their strong competitive edge, with recommendations to focus on companies like Sailun Tire and Linglong Tire [4]. - **Consumer Electronics**: A gradual recovery is anticipated, with upstream material companies expected to benefit from increased demand in the panel supply chain [4]. - **Cyclical Industries**: Phosphate and fluorine chemical sectors are highlighted for their resilience, with recommendations for companies like Yuntianhua and Juhua [5][8]. - **Leading Companies**: The report suggests that leading companies in the chemical sector, such as Wanhua Chemical and Hualu Hengsheng, will benefit from economic recovery and demand resurgence [8].

Core Viewpoint - The company emphasizes its commitment to innovation-driven development and market competition, focusing on fine chemicals and achieving domestic production of key products like Vitamin E and A [2] Group 1: Company Strategy - The company relies on two core platforms: chemical and biological, to develop functional chemicals in nutrition, flavors, new materials, and raw pharmaceuticals [2] - The company adheres to the values of "innovation, people-oriented, and competitive success," and follows a development approach of "integration, serialization, and collaboration" [2] Group 2: Product Development - The company has successfully achieved the domestic production of various products, including Vitamin E, Vitamin A, PPS, and methionine, contributing to industrial transformation and upgrading [2] Group 3: Future Focus - The company plans to enhance its technological innovation, global layout, and digital intelligence to strengthen management and improve overall competitiveness [2]

Investment Rating - The investment rating for the company is "Buy" with a target of outperforming the industry index by more than 15% over the next six months [5][19]. Core Views - The company's profitability has significantly increased year-on-year, with a notable rise in net profit driven by the life nutrition products segment [2][11]. - The vitamin industry is expected to continue its upward trend, benefiting from increased market demand and price fluctuations [4][11]. - The company is implementing cost reduction and efficiency improvement measures across its two main segments to enhance competitiveness and support future growth [10][11]. Financial Performance Summary - For the first half of 2025, the company reported a revenue of 4.323 billion, a decrease of 1.87% year-on-year, while net profit increased by 113.52% to 673 million [1][2]. - The overall gross margin for the first half of 2025 was 39.82%, an increase of 4.43 percentage points compared to the same period in 2024 [2]. - The life nutrition products segment generated a revenue of 2.034 billion, a slight increase of 0.58% year-on-year, with a gross margin of 54.95%, up 15.41 percentage points [4][10]. Cash Flow and Financial Ratios - The net cash flow from operating activities for the first half of 2025 was 798 million, a significant increase of 281.20% year-on-year [3]. - The company’s cash and cash equivalents at the end of the period stood at 2.709 billion, an increase of 84.43% year-on-year [3]. - The projected earnings per share (EPS) for 2025 is 1.16, with corresponding P/E ratios of 13.5, 9.9, and 9.2 for the years 2025, 2026, and 2027 respectively [11].